Mass spectrometry and neonatal screening

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2015Publisher:JLEJournal:Annales de biologie clinique, volume 73, pages 107-111 (issn: 0003-3898,

Copyright policy )

Authors: Roselyne, Garnotel;

doi: 10.1684/abc.2014.1021

pmid: 25582727

Mass spectrometry and neonatal screening

- Summary
- Subjects
- Metrics

Abstract

Tandem mass spectrometry allows to screen many inherited metabolic diseases within a single blood spot. It is possible to screen newborns for amino and organic acid, fatty acid oxidation disorders and lysosomal diseases. Tandem mass spectrometry neonatal screening is not yet realized in France in 2014.

Related Organizations

Memorial Hospital of South Bend
United States
Centre Hospitalier Universitaire de Reims
France

Keywords

Blood Specimen Collection, Neonatal Screening, Tandem Mass Spectrometry, Infant, Newborn, Humans, France, Mass Spectrometry, Metabolism, Inborn Errors

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average